Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions
CCL25 疗法需要通过微粒控制释放，以避免强烈的炎症反应
期刊:Journal of Nanobiotechnology
影响因子:10.6
doi:10.1186/s12951-021-00830-7
J Spinnen, K Fröhlich, N Sinner, M Stolk, J Ringe, L Shopperly, M Sittinger, T Dehne, M Seifert
